Company Overview
Snapshot
Founded in October 2014 by Yoni Epstein, Anchora Medical operates with 1–10 employees. The company has raised $5.2 million across 3 funding rounds from 5 investors.
Business overview
Anchora Medical specializes in developing minimally invasive suturing devices for both endoscopic (GI) and laparoscopic (hernia) procedures. Their core technology involves sterile, automatic, single-use suturing devices that utilize tiny stainless steel or nitinol anchors threaded on surgical thread to create running or interrupted sutures in soft tissue. The company's product, Su2ura Approximation Device, is designed for use in minimally invasive surgeries and is currently in clinical use, serving the healthcare sector, particularly hospitals and surgeons.
Strategic signal
Anchora Medical received FDA clearance for its Su2ura Minimally-Invasive Surgical Suturing Device in June 2021. This regulatory approval is a significant validation of the company's technology and allows for broader market access and clinical adoption of their device, signaling strong progress in product commercialization and potential for growth in the medical device market.
Log in to access full profile ›Company Intelligence Q&A
- When did Anchora Medical receive FDA clearance for its Su2ura device?
- Anchora Medical received FDA clearance for its Su2ura Minimally-Invasive Surgical Suturing Device in July 2021.
- Which investors participated in Anchora Medical's February 2020 funding round?
- In February 2020, Anchora Medical closed a funding round led by.
- Who is the CEO and Co-founder of Anchora Medical?
- Yoni Epstein is the CEO and Co-founder of Anchora Medical.
- What type of procedures are Anchora Medical's devices designed for?
- Anchora Medical's devices are designed for minimally invasive suturing in both endoscopic (GI) and laparoscopic (hernia) procedures.